Order Article Reprints

Dröge LH, Karras PJ, Guhlich M, Schirmer MA, Ghadimi M, Rieken S, Conradi L-C, Leu M. Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities. Cancers. 2021; 13(8):1834. https://doi.org/10.3390/cancers13081834

Dröge, Leif Hendrik, Philipp Johannes Karras, Manuel Guhlich, Markus Anton Schirmer, Michael Ghadimi, Stefan Rieken, Lena-Christin Conradi, and Martin Leu. 2021. "Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities" Cancers 13, no. 8: 1834. https://doi.org/10.3390/cancers13081834

Dröge, L. H., Karras, P. J., Guhlich, M., Schirmer, M. A., Ghadimi, M., Rieken, S., Conradi, L.-C., & Leu, M. (2021). Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities. Cancers, 13(8), 1834. https://doi.org/10.3390/cancers13081834